← Back
Data updated: Mar 10, 2026
CLINIGEN HLTHCARE
ImmunologyInfectious Disease
CLINIGEN HLTHCARE is a specialty pharmaceutical company focused on Immunology, Infectious Disease.
1991
Since
1
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 50%
1 drugs
Infectious Disease 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 1991-09-27
- Latest
- 2020-10-28
- Applications
- 1